Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

August 28, 2020

Study Completion Date

January 31, 2023

Conditions
Chemotherapy-induced Thrombocytopenia
Interventions
DRUG

Avatrombopag

Oral avatrombopag tablet

DRUG

Placebo Oral Tablet

Placebo comparator tablet

Trial Locations (55)

17325

Dova Site, Gettysburg

30912

Dova Site, Augusta

41101

Dova Site, Ashland

44718

Dova Site, Canton

47403

Dova Site, Bloomington

55417

Dova Site, Minneapolis

60076

Dova Site, Skokie

60426

Dova Site, Harvey

67214

Dova Site, Wichita

90403

Dova Site, Santa Monica

92501

Dova Site, Riverside

92801

Dova Site, Anaheim

93309

Dova Site, Bakersfield

188663

Dova Site, Saint Petersburg

357502

Dova Site, Pyatigorsk

02114

Dova Site, Boston

Unknown

Dova Site, Harbin

Dova Site, Linyi

Dova Site, Neijiang

Dova Site, Shanghai

Dova Site, Tianjin

Dova Site, Budapest

Dova Site, Debrecen

Dova Site, Nyíregyháza

Dova Site, Törökbálint

Dova Site, Lublin

Dova Site, Olsztyn

Dova Site, Prabuty

Dova Site, Tomaszów Mazowiecki

Dova Site, Warsaw

Dova Site, Arkhangelsk

Dova Site, Kazan'

Dova Site, Kursk

Dova Site, Moscow

Dova Site, Novosibirsk

Dova Site, Omsk

Dova Site, Saint Petersburg

Dova Site, Saransk

Dova Site, Sochi

Dova Site, Belgrade

Dova Site, Kamenitz

Dova Site, Kragujevac

Dova Site, Cherkasy

Dova Site, Chernihiv

Dova Site, Chernivtsi

Dova Site, Ivano-Frankivsk

Dova Site, Kharkiv

Dova Site, Kherson

Dova Site, Kropyvnytskyi

Dova Site, Kyiv

Dova Site, Odesa

Dova Site, Sumy

Dova Site, Ternopil

Dova Site, Uzhhorod

Dova Site, Vinnytsia

All Listed Sponsors
lead

Sobi, Inc.

INDUSTRY

NCT03471078 - Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers | Biotech Hunter | Biotech Hunter